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Malaria is endemic in the North of Brazil. However, Hyperreactive Malarious Splenomegaly
(HMS)  has been rarely described. Splenomegaly in HIV/Aids infection has a large differential
diagnosis,  but malaria is a cause of gross splenomegaly, regardless of the HIV status. In this
paper,  we report the case of a 50-year-old man, HIV positive, with massive splenomegaly
and  multiple malaria infections in the past. He fulﬁlled the criteria for HMS, received a short
course  of anti-malarial treatment and weekly quimioproﬁlatic Chloroquine. In 9 months,yperreactivemalarious
plenomegaly
ids
he  had great clinical and laboratorial improvement conﬁrming the HMS, a rare diagnosis in
Brazil.
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yperreactive malarious splenomegaly (HMS), known as Trop-
cal  Splenomegaly Syndrome,1 despite being common in
alaria-endemic regions and in travelers from non-endemic
reas,2 has low prevalence in Brazil.3 The HMS  is presented
s  an exaggerated immune response to infection by Plasmo-
ium,  resulting in nonspeciﬁc, hyper-immunoglobulin M (IgM)
olyclonal immunoglobulin production by B lymphocytes,
nd the formation of immune complexes that are deposited
n  the spleen. The criteria for the diagnosis of HMS are:
plenomegaly (>10 cm below the left costal margin), increased
gM  that exceeds twice the reference value, high titers of
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laboratory improvement after treatment with anti-malarial
drugs.4,5 The association with HIV infection is poorly doc-
umented, although HIV and malaria are endemic in many
tropical  regions.
Case  report
A 50-year-old man  was admitted to the infectious diseases
sector  of UHL (University Hospital of Londrina, Brazil) in Febru-.N. Tano).
ary  2012. On admission, he complained of progressive weight
loss,  asthenia, and abdominal discomfort for two months,
associated with fever for three days.
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Fig. 2 – CT abdomen nine months after chloroquine use.
Table 1 – Laboratory tests.
Admission 1 month 9 month
Hb (g/dL) 5.6 10.2 13.7
Platelets/mL 56,000 100,000 99,000
Leukocytes (/L) 4300 3500 5800
IgM  (mg/dL) 1790 – 473
Protein electrophoresis
(Hypergamma %)
51 35.8 30
Albumin (g/dL) 2.5 4.5 4.68566  b r a z j i n f e c t d 
Physical examination showed discrete hepatomegaly and
signiﬁcant  splenomegaly, about 20 cm below the left costal
margin.  He reported having lived in the cities of Lon-
drina/PR and Itaituba/PA, where he worked in mining
for  about seven months a year. He had a previous his-
tory  of 20 episodes of malaria, and had been diagnosed
with HIV in the past two years, with irregular use of
antiretroviral therapy. Laboratory tests on admission showed:
Hb  = 5.6 g/dL, platelets = 61,000/mm3; leukocytes = 4300/mm3
(67% neutrophils), protein electrophoresis with hypergamma-
globulinemia = 51%; albumin = 2.5 g/dL; IgM = 1790 mg/dL (NR:
57-212),  CD4 = 115/mm3 and viral load = 2352 copies/mL. Anti-
body  (indirect immunoﬂuorescence) anti-plasmodium vivax
was  1/1280 and anti-plasmodium falciparum = 1/320. The
direct  method for Plasmodium sp. thick smear was  negative,
as  well as polymerase chain reaction (PCR). On admission, the
ﬁrst  diagnostic hypothesis was  sepsis after urinary tract infec-
tion.  Once E. coli bacteria were isolated from blood and urine,
the  treatment with Ciproﬂoxacin had good response, but the
urinary  infection could not explain the splenomegaly.
Mieloculture was  performed and fungi and Leishmania in
two  samples were  searched, both turned out negative, ruling
out  histoplasmosis and visceral leishmaniasis. Inoculation in
mice bone marrow blood resulted negative for Leishmania.
Parasitical exams were  negative in feces.
On admission, serology for toxoplasmosis and
cytomegalovirus had positive IgM for both microorgan-
isms, which ultimately proved to be false-positive. Likewise,
anti-HCV  was  positive at low titers, with negative PCR for HCV.
Abdominal  tomography showed a 3700 mL  spleen at admis-
sion  and 9 months after initiation of treatment, it reduced
to  1358 mL  (64% reduction), demonstrating homogeneous
parenchymal liver and spleen without portal hypertension
(Figs. 1 and 2).Having  deﬁned the diagnosis of HMS  the ﬁrst cycle with pri-
maquine  and chloroquine was  carried out for 7 days, followed
Fig. 1 – CT abdomen at admission.Spleen volume
CT  abdomen (vol/mL)
3700  – 1358
by chloroquine 300 mg/week. Follow-up exams in the ﬁrst and
ninth  month are shown in Table 1.
Discussion  and  conclusion
The development of HMS is associated with two main factors:
repeated  exposure to Plasmodium species and genetic pre-
disposition.  Countries with high endemism for malaria have
prevalence  of HMS  ranging from 1 to 2% in Nigeria and 80% in
certain tribes of New Papua Guinea.2 In Brazil, the prevalence
is  low in the Amazon region.3 Alecrim6 examined a population
of  890 people living in a hyper-endemic area of Manaus, and
found  only 10 people with a persistent spleen enlargement. Of
these, four met  the criteria for Tropical Splenomegaly, as it was
known  at the time, three of them were brothers, underscoring
the  importance of genetic predisposition in tribal HMS.
The  main genetic factors related to high population
prevalence of HMS  were  HLA-DR2 and high levels of HLA
heterozygous,4,7 in addition to the high frequency of the hap-
lotype  IGHG3.8
It is believed that patients with HMS  have a hyper pro-
duction of polyclonal IgM,1 which is linked to suppressor T
lymphocytes (cytotoxic phenotype), causing the elimination
of  the parasite, as well as generating immune complexes that
are  deposited in the spleen, thus resulting in splenomegaly.
In  this case, the overproduction of nonspeciﬁc poly-
clonal IgM explains the false positive results for both
b r a z j i n f e c t d i s . 2 0 1 
Table 2 – Diagnostic feature of hyperreactive malarious
splenomegaly (HMS) – Fakunle criteria.
Major criteria Minor criteria
Splenomegaly > 10 cm Hepatic sinusoidal
lymphocytosis
IgM  > 2SD of local mean Hypersplenism
High titers of antimalarial
antibodies
Lymphocytic proliferation
Clinical  and immunological
response  to antimalarial drug
Normal cellular and humoral
immune  response to antigenic
challenge  excluding
Plasmodium
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ytomegalovirus and toxoplasmosis, in addition to high titers
f  IgM (one of the diagnostic criteria).
The diagnosis of tropical splenomegaly syndrome requires
xclusion of other causes of massive splenomegaly. However,
eﬁnite  diagnosis depends on speciﬁc criteria, such as the
akunle4,5,9 criteria shown in Table 2. These criteria are not
ifferent  for HIV patients.10 In the case herein reported, the
atient  met  all major criteria in addition to hypersplenism as
 minor criterion, thus conﬁrming the diagnosis.
Although HIV/AIDS and malaria coexist with high preva-
ence  in many  countries of sub-Saharan Africa, few cases have
een  published linking the two diseases.10,11 In individuals
ith AIDS there is an inversion in the CD4/CD8 ratio due to
ecrease  in number and function of CD4T lymphocytes, while
n  HMS  there is an increase in this ratio due to decreased
umber of CD8T lymphocytes. One hypothesis is that this
ifference  may  prevent patients with HIV from manifesting
MS  after repeated Malaria infections, explaining therefore
he  low number of cases associating the two diseases. How-
ver,  further studies should be carried out to better identify
he  immunological relationship between them.
HMS  treatment consists of a short cycle of anti-malarial
rug, and the use of chemoprophylaxis (chloroquine in this
ase)  for a period of 9–26 months in patients who remain
xposed to malaria, to prevent new infections and to have the
escribed  immunomodulatory effect of chloroquine.12
Therefore, we  must be alert to cases of massive
plenomegaly in patients living in endemic areas of malaria
n  Brazil, or those who migrated from these regions. Further-
ore,  HMS  needs to be considered as a differential diagnosis
n  patients with splenomegaly and AIDS.
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Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
Acknowledgment
We  would like to thank André Machado Siqueira from Univer-
sidade  Estadual do Amazonas (Amazonas State University) for
the suport in malaria PCR.
 e  f  e  r  e  n  c  e  s
1. Bryceson A, Fakunle YM, Fleming AF, et al. Malaria and
splenomegaly (letter). Trans R Soc Trop Med  Hyg. 1983;77:
879.
2. Crane GG. Recent studies of hyperreactive malarious
splenomegaly (tropical splenomegaly syndrome) in Papua
New  Guinea. P N G Med J. 1986;29:35–40.
3.  Doenc¸as  Infecciosas e Parasitárias: Enfoque
Amazônico/Raimundo Nonato Queiroz de Leão
{coordenador}. Belém: Cejup, UEPA, Instituto Evandro
Chagas; 1997.
4. Fakunle YM. Tropical splenomegaly. Clin Hematol.
1981;10:963–75.
5. Bates I, Bedu-Addo G. Review of diagnostic criteria of
hyperreactive malarial splenomegaly. Lancet. 1997;349:
1179.
6. Alecrim, WD. Estudo clínico e epidemiológico da malária no
Rio  Ituxi-Amazonas. 1979. 115p. Tese (mestrado).
Universidade de Brasiília, Brasília. 1979.
7.  Bhatia KK, Crane GG. HLA heterozygosity and hyperreactive
malarious splenomegaly in the Upper Watut Valley of Nova
Guinéa.  P N G Med J. 1989;32:277–86.
8.  Kelly KM. IGHG3 G and the pathogenesis of hyperreactive
malarious splenomegaly. Med Hypotheses. 1996;46:135–9.
9. Ranjan K, Singh. Hyperreactive malarial splenomegaly in
expatriates.  Travel Med Infect Dis. 2007;5:24–9.
0. De Iaco G, Saleri N, Perandin F, et al. Case Report.
Hyper-reactive malarial splenomegaly in a patient with
human  immunodeﬁciency virus. Am J Trop Med Hyg.
2008;78:239–40.
1. Lowenthal MN, Horowitz J, Gaspar N, et al. Hyperreactive
malarial splenomegaly and AIDS: proguanil prevents
recurrent pneumonia. Trans R Soc Trop Med Hyg.
1996;90:313–4.
2. Hoffman SL, Piessens WF, Ratiwayanto S, et al. Reduction of
suppressor  T lymphocytes in the tropical splenomegaly
syndrome. N Engl J Med. 1984;310:337–41.
